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Abstract 47 
Mitochondria are cellular organelles with crucial functions in the generation and distribution of ATP, 48 
the buffering of cytosolic Ca
2+
 and the initiation of apoptosis. Compounds that interfere with these 49 
functions are termed mitochondrial toxins, many of which are derived from microbes, such as 50 
antimycin A, oligomycin A, and ionomycin. Here, we identify the mycotoxin phomoxanthone A 51 
(PXA), derived from the endophytic fungus Phomopsis longicolla, as a mitochondrial toxin. We show 52 
that PXA elicits a strong release of Ca
2+
 from the mitochondria but not from the ER. In addition, PXA 53 
depolarizes the mitochondria similarly to protonophoric uncouplers such as CCCP, yet unlike these, it 54 
does not increase but rather inhibits cellular respiration and electron transport chain activity. The 55 
respiration-dependent mitochondrial network structure rapidly collapses into fragments upon PXA 56 
treatment. Surprisingly, this fragmentation is independent from the canonical mitochondrial fission 57 
and fusion mediators DRP1 and OPA1, and exclusively affects the inner mitochondrial membrane, 58 
leading to cristae disruption, release of pro-apoptotic proteins, and apoptosis. Taken together, our 59 
results suggest that PXA is a mitochondrial toxin with a novel mode of action that might prove a 60 
useful tool for the study of mitochondrial ion homeostasis and membrane dynamics. 61 
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Introduction 62 
Mitochondria are cellular organelles that are crucial to almost all eukaryotic organisms. Among their 63 
most important functions are generation and distribution of ATP, buffering of cytosolic Ca
2+
 and, in 64 
animal cells, initiation of apoptosis. Disturbance of these or other functions by mitochondrial toxins 65 
can lead to cellular stress and cell death
1,2
. 66 
Mitochondria produce ATP through oxidative phosphorylation (OXPHOS), which depends on the 67 
electron transport chain (ETC) embedded in the inner mitochondrial membrane (IMM). The ETC 68 
pumps protons out of the mitochondrial matrix and into the mitochondrial intermembrane space. This 69 
generates a proton gradient (ΔpHm) and, consequently, a membrane potential (ΔΨm) across the IMM. 70 
The ΔΨm is then used to drive the mitochondrial ATP synthase
3
.  71 
To provide all regions within the cell with sufficient ATP, mitochondria often form a network that 72 
constantly undergoes balanced fission and fusion. This allows remodelling of the network as well as 73 
removal and recycling of damaged mitochondria through mitophagy
1,4,5
. Excessive fission can be 74 
triggered by mitochondrial toxins that cause loss of ΔΨm, such as the protonophore carbonyl cyanide 75 
m-chlorophenyl hydrazone (CCCP)
6
. 76 
The ΔΨm also plays a role in the mitochondrial buffering of cytosolic Ca
2+
. Normally, the cytosol of a 77 
typical animal cell contains only a very low Ca
2+
 concentration ([Ca
2+
]cyt, ~0.1 µM), whereas the 78 
concentration of Ca
2+
 within the endoplasmic reticulum ([Ca
2+
]ER, >100 µM) or outside the cell 79 
([Ca
2+
]ext, >1,000 µM) is up to 10,000 fold higher
2
. In response to certain stimuli, Ca
2+
 channels in the 80 
ER and / or the plasma membrane open to release Ca
2+
 into the cytosol as a second messenger. 81 
Mitochondria contribute to removal of cytosolic Ca
2+
 by uptake into their matrix via ΔΨm-driven Ca
2+
 82 
transporters. After that, a slow, regulated efflux moves the Ca
2+
 out of the matrix and into the cristae, 83 
which are folds in the IMM, from where it is slowly released and shuttled back to the ER
2,7,8,9
. A 84 
separate mechanism through which Ca
2+
 can cross the IMM is the mitochondrial permeability 85 
transition pore (mPTP), which can open irreversibly in response to severe mitochondrial stress. The 86 
mPTP directly connects the mitochondrial matrix with the cytosol to allow the free exchange of 87 
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molecules up to 1.5 kDa in size, including Ca
2+
. Irreversible mPTP opening leads to release of 88 
mitochondrial Ca
2+, loss of ΔΨm, swelling of the matrix, and eventually mitochondrial outer membrane 89 
permeabilisation (MOMP)
10, 11
. 90 
In animal cells, MOMP initiates apoptosis. Several proteins normally contained in the cristae attain a 91 
pro-apoptotic function if they pass the outer mitochondrial membrane (OMM) and are released into 92 
the cytosol. Among these proteins are cytochrome c (CYCS), SMAC (DIABLO), and OMI (HTRA2). 93 
Cytosolic CYCS becomes part of the caspase-activating apoptosome complex, while DIABLO and 94 
HTRA2 bind and inhibit the inhibitor of apoptosis proteins (IAPs), thus attenuating their inhibition of 95 
caspases
1
. MOMP can be caused either passively through rupture of the OMM, such as triggered by 96 
the mPTP, or actively through the formation of pores in the OMM by the pro-apoptotic proteins BAK 97 
and BAX, which can be induced in response to severe cellular stress
12
. 98 
A variety of mitochondrial toxins with different effects and molecular targets is known today
13
. 99 
Several of these toxins are natural products, such as the Streptomyces-derived ETC inhibitor 100 
antimycin A and the ATP synthase inhibitor oligomycin A. 101 
Phomoxanthone A and B (PXA and PXB) are natural products named after the fungus Phomopsis, 102 
from which they were first isolated, and after their xanthonoid structure (Figure S1). PXA is a 103 
homodimer of two acetylated tetrahydroxanthones symmetrically linked at C-4,4', whereas PXB is 104 
structurally almost identical but asymmetrically linked at C-2,4'. Both possess antibiotic activity 105 
against diverse organisms from all biological kingdoms. Originally described in 2001, PXA and PXB 106 
were tested against the protozoan Plasmodium falciparum, the Gram-positive Mycobacterium 107 
tuberculosis, and three animal cell lines. In all of these organisms, both PXA and PXB showed 108 
significant cytotoxic activity, with PXA being more toxic in every case
14
. A later study in different 109 
organisms produced similar results, showing that PXA inhibits the growth of the Gram-positive 110 
Bacillus megaterium, the alga Chlorella fusca, and the fungus Ustilago violacea
15
. 111 
We previously showed that PXA induces apoptosis in human cancer cell lines. Signs of apoptosis were 112 
observed as early as after 4 h of treatment with low micromolar doses of PXA
16,17
. However, the 113 
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mechanism by which PXA causes apoptosis or cytotoxicity in general has never before been 114 
investigated. 115 
The aim of this study was to elucidate the mechanism through which PXA exerts its toxicity. 116 
Following our initial results, we hypothesized that PXA directly affects the mitochondria and thus 117 
investigated its effects on the ETC, ΔΨm, ATP production, Ca
2+
 buffering, and mitochondrial 118 
morphology. It appears that PXA is a mitochondrial toxin that specifically affects the inner 119 
mitochondrial membrane, leading to loss of ΔΨm, ETC inhibition, Ca
2+
 efflux, mitochondrial 120 
fragmentation, cristae disruption, and finally to the release of mitochondrial pro-apoptotic factors. 121 
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Results 122 
PXA induces Ca
2+
 release from an intracellular store 123 
To determine how PXA induces apoptosis, we analysed its effect on cellular Ca
2+
 levels since ionic 124 
imbalance can be an apoptotic trigger. Treatment of Ramos cells with PXA resulted in a strong, steady 125 
increase of [Ca
2+
]cyt (Figure 1a). Interestingly, there was a delay of about 2–5 min between addition of 126 
PXA and increase in [Ca
2+
]cyt. Since this pattern of Ca
2+
 release is similar to that caused by the tyrosine 127 
phosphatase inhibitor pervanadate (VO4
3−
) (Figure S2a), and since tyrosine phosphatase inhibition can 128 
induce apoptosis, we tested the effect of PXA on tyrosine phosphorylation. However, in contrast to 129 
pervanadate, we could not detect any effect (Figure S2b). In a broader picture, PXA had no inhibitory 130 
effect on any of 141 protein kinases against which we tested it (Table S1). 131 
We next tried to determine the origin of the released Ca
2+
. Since PXA increases [Ca
2+
]cyt even in 132 
absence of extracellular Ca
2+
, we tested if it releases Ca
2+
 from the ER. Using thapsigargin, which 133 
causes a net efflux of Ca
2+
 from the ER, we could induce an increase in [Ca
2+
]cyt even after PXA-134 
inducible Ca
2+
 stores were depleted (Figure 1b), suggesting that the Ca
2+
 released by PXA at least 135 
partially originates from a source other than the ER. 136 
PXA induces Ca
2+
 release mainly from the mitochondria 137 
To quantify the effect of PXA on Ca
2+
 stores, we used HeLa cells expressing CEPIA Ca
2+
 probes 138 
targeted to either the ER or the mitochondria. Although PXA provoked some Ca
2+
 release from the 139 
ER, it was much slower and weaker than that evoked by thapsigargin (Figure 1c). Mitochondria, 140 
however, were quickly and severely depleted (Figure 1d). This effect of PXA on mitochondrial Ca
2+
 141 
was confirmed in Ramos cells, making use of the Ca
2+
 probe Pericam (Figure 1e). 142 
 143 
Mitochondrial Ca
2+
 release caused by PXA is independent from the mPTP 144 
Large-scale Ca
2+
 efflux from the mitochondria can result from persistent opening of the mPTP. We 145 
thus tested whether PXA induces mPTP opening by using the cobalt/calcein method, comparing PXA 146 
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to the mPTP inducer ionomycin (IM). While IM caused a strong decrease in mitochondrial calcein 147 
fluorescence as expected, PXA had no observable effect (Figure 1f & g; Movies S1–S3). Similar 148 
results were obtained by further live measurement using flow cytometry (Figure 1h). In addition, we 149 
tested whether the mPTP inhibitor cyclosporin A (CsA) can prevent the mitochondrial Ca
2+
 release 150 
caused by PXA. We measured mitochondrial Ca
2+
 retention capacity in isolated mitochondria, 151 
comparing PXA to IM and CCCP. This was done in either normal isolated mitochondria or 152 
mitochondria loaded with Ca
2+
, and in the presence of either CsA or its derivative cyclosporin H 153 
(CsH), which does not affect the mPTP (Figure 2)
18
. While PXA caused a decrease in calcium green 154 
fluorescence, indicating Ca
2+
 release, under every condition, i.e. regardless of Ca
2+
 loading and also in 155 
the presence of CsA, IM had an observable effect only in loaded mitochondria, but also regardless of 156 
CsA. On the other hand, CCCP caused a release of Ca
2+
 only in the presence of CsH but not CsA, 157 
indicating that CCCP-induced Ca
2+
 release does indeed depend on the mPTP, unlike that induced by 158 
PXA. Taken together, these results indicate that PXA causes mitochondrial Ca
2+
 release largely 159 
independent from the mPTP. 160 
PXA depolarises the mitochondria but does not uncouple cellular respiration 161 
A change in [Ca
2+
]mito likely correlates with changes in other mitochondrial ion gradients. Uptake of 162 
Ca
2+
 into the mitochondrial matrix is driven by ΔΨm. We thus analysed the effect of PXA on ΔΨm. 163 
Indeed, PXA caused immediate mitochondrial depolarisation similar to CCCP, both in whole cells and 164 
isolated mitochondria (Figure 3a & b). The EC50 for PXA-induced loss of ΔΨm in Ramos cells was 165 
determined to be 1.1±0.3 µM (Figure S3). The key contributor to ΔΨm is ΔpHm, which is maintained 166 
via cellular respiration by consumption of O2. If the PXA-induced loss of ΔΨm was caused by loss of 167 
ΔpHm downstream of the ETC, as in case of CCCP, it would be accompanied by an increase in 168 
respiration to compensate for the loss. Therefore, we measured cellular O2 consumption upon 169 
increasing concentrations of either PXA or CCCP. As expected, CCCP caused a dose-dependent 170 
increase in O2 consumption. However, in contrast to CCCP, PXA caused no increase but rather a slight 171 
decrease in O2 consumption (Figure 3c). An overview of the kinetics of the effects of PXA on 172 
[Ca
2+
]cyt, [Ca
2+
]mito, O2 consumption, and ΔΨm is presented in Figure 3d. 173 
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PXA inhibits cellular respiration by disrupting the electron transport chain 174 
Since PXA had a moderate inhibitory effect on cellular O2 consumption under basal conditions, we 175 
next measured O2 consumption after the respiration rate was first increased by CCCP. Here, treatment 176 
with PXA caused a strong decrease in O2 consumption to levels below baseline (Figure 4a). It thus 177 
appeared likely that PXA, unlike CCCP, is not an inducer but rather an inhibitor of cellular respiration 178 
and of the ETC. We therefore compared PXA to known ETC inhibitors: rotenone (complex I), 179 
thenoyltrifluoroacetone (TTFA; complex II), antimycin A (complex III), sodium azide (NaN3; 180 
complex IV), and oligomycin A (complex V / ATP synthase). In an O2 consumption assay, PXA 181 
caused a strong decrease in cellular respiration, both after CCCP treatment and under basal conditions, 182 
similar to that caused by rotenone, antimycin A, and azide (Figure 4b). Oligomycin A expectedly 183 
inhibited respiration under basal conditions but not after CCCP treatment since CCCP uncouples 184 
respiration from ATP synthesis. TTFA did not have a significant effect, probably because complex II 185 
is not involved in respiration if complex I substrates are available
19
. 186 
Since a functional ETC is required for ATP synthesis by OXPHOS, we also compared PXA to known 187 
ETC inhibitors in this context. Indeed, PXA as well as all tested ETC inhibitors strongly reduced 188 
cellular ATP levels if galactose was the only available sugar and ATP had to be synthesised via 189 
OXPHOS instead of glycolysis (Figure 4c). Thus assuming that PXA targets the ETC, we tried to 190 
determine if it specifically inhibits one of the ETC complexes. This experiment was performed in 191 
permeabilized cells, comparing PXA to rotenone. Succinate, which induces complex II-dependent 192 
respiration only if complex I is inhibited, alleviated rotenone-induced inhibition of O2 consumption 193 
but had only a marginal effect in PXA-treated cells. In contrast, duroquinol, which induces 194 
complex III-dependent respiration, increased O2 consumption in both PXA-treated as well as rotenone-195 
treated cells back to levels before inhibition (Figure 4d). These data suggest that PXA might either 196 
affect both complex I and II or the shuttling of electrons between complex I/II and III. 197 
Comparison of PXA with other ETC inhibitors 198 
While PXA inhibits the ETC as well as ATP synthesis, it differs from the other ETC inhibitors used in 199 
this study concerning its effects on Ca
2+
 and ΔΨm. Unlike PXA, neither CCCP nor any of the tested 200 
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ETC inhibitors with the exception of antimycin A caused a noticeable release of Ca
2+
 (Figure S4a), 201 
and that caused by antimycin A was much weaker and had an earlier but slower onset than the one 202 
caused by PXA. Similarly, while both CCCP and PXA induced a strong and immediate decrease in 203 
ΔΨm, none of the other ETC inhibitors except antimycin A had any effect on ΔΨm, and that of 204 
antimycin A was much slower and weaker (Figure S4b). Since we previously showed that PXA is 205 
cytotoxic and induces apoptosis, we also compared it to CCCP, ETC inhibitors, ionomycin (control for 206 
Ca
2+
 release) and staurosporine (control for cytotoxicity / apoptosis) in these regards. PXA, 207 
staurosporine and CCCP strongly induced apoptosis, while the ETC inhibitors and ionomycin were 208 
much weaker inducers in Ramos cells and did not noticeably induce apoptosis at all in Jurkat cells 209 
(Figure 5a & b). Dependency on OXPHOS for ATP synthesis, which considerably increased the 210 
toxicity of the ETC inhibitors, appeared to have no effect on the toxicity of PXA or staurosporine 211 
(Figure 5c & d). These observations indicate that PXA probably causes cytotoxicity in general and 212 
apoptosis in particular not via its effects on the ETC, ΔΨm, or [Ca
2+
]mito, but rather that all of these 213 
events might have a common cause further upstream. 214 
PXA causes irreversible cleavage of OPA1 mediated by OMA1 but not YME1L1 215 
Several stress conditions including loss of ΔΨm and low levels of ATP can induce cleavage of the 216 
IMM fusion regulator OPA1 by the protease OMA1 (ref. 
20
). Additionally, OPA1 is also cleaved by 217 
the protease YME1L1, resulting in fragments of different size. We treated MEF cells deficient for 218 
either one or both of these proteases with either PXA or CCCP. We observed that PXA, like CCCP, 219 
caused stress-induced OPA1 cleavage that was dependent on OMA1, whereas expression of YME1L1 220 
did not have any visible effect on PXA-induced OPA1 cleavage (Figure 6a). Similarly to their effect in 221 
MEF cells, PXA and CCCP induced cleavage of OPA1 in Ramos and Jurkat cells within minutes. 222 
Interestingly, and unlike CCCP, removal of PXA did not enable recovery of the long OPA1 forms 223 
(Figure 6b). This prompted us to also investigate the effects of removal of PXA on cytotoxicity. 224 
Indeed, though PXA was about five-fold less toxic if removed after a few minutes, it still irreversibly 225 
primed the cells for death (Figure 6c). It thus appears that at least some of the effects of PXA on the 226 
cells are irreversible. 227 
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PXA induces fragmentation of the inner but not of the outer mitochondrial 228 
membrane independently of OMA1, OPA1, and DRP1 229 
Excessive processing of OPA1 by OMA1 changes mitochondrial cristae morphology, resulting in the 230 
release of pro-apoptotic factors such as CYCS and SMAC. We therefore investigated the effects of 231 
PXA on SMAC localisation and on recruitment of BAX to the OMM. We observed that PXA indeed 232 
induced recruitment of GFP-BAX to the mitochondria, with concurrent release of SMAC-mCherry 233 
into the cytosol, within about 2–3 h (Figure 7a & Movie S4; quantification shown in Figure S5). 234 
OPA1 processing by OMA1 also prevents IMM fusion and, if excessive, results in mitochondrial 235 
fragmentation. Intriguingly, PXA caused rapid fragmentation of the mitochondrial network within 236 
minutes (Figure 7b), and independent of the cells’ OMA1 or YME1L1 status (Figure 7c, left panels; 237 
Movie S5–S7). The persistence of PXA-induced mitochondrial fragmentation in OMA1-YME1L1 238 
DKO cells indicates that this process is independent of OPA1 cleavage. 239 
Mitochondrial fission is also regulated by the dynamin DRP1, which mediates OMM fission. We thus 240 
tested the effect of PXA on the mitochondrial morphology in DRP1-deficient MEF cells. Again, 241 
fragmentation was observed within minutes after treatment (Figure 7c, right panel; Movie S8). We 242 
next used dual staining of both the matrix (via HSP60) as well as the OMM (via TOMM20) to 243 
determine whether both or only one of these structures are affected by PXA. CCCP was used as a 244 
positive control for fragmentation. As expected, CCCP could not induce fragmentation in DRP1-KO 245 
cells, and in WT cells it induced fragmentation of both the IMM and OMM together (Figure 8a & b). 246 
In contrast, in the WT cells treated with PXA, fragmentation was much stronger and resulted in 247 
smaller fragments. More intriguingly, in DRP1-KO cells treated with PXA, only the matrix appeared 248 
to have fragmented, whereas the OMM appeared to have shrunken around the matrix fragments but 249 
otherwise remained connected (Figure 8a & b). This effect could also be observed in cells deficient for 250 
both DRP1 and OPA1 (Figure S6) demonstrating that PXA acts independently of canonical regulators 251 
of mitochondrial fission. Finally, a close examination of the mitochondrial ultrastructure by 252 
transmission electron microscopy revealed that PXA causes OMA1-independent disruption of 253 
mitochondrial matrix morphology, complete loss of cristae, and condensation of IMM structures at the 254 
OMM (Figure 8c). 255 
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Taken together, our results show that PXA disturbs mitochondrial form and function in several ways. 256 
Some effects, such as the rapid inhibition of both ΔΨm and the ETC at the same time, the delayed 257 
release of mitochondrial Ca
2+
, and the fragmentation of the inner but not the outer mitochondrial 258 
membrane, are unique and indicate a mode of action that is distinct from all other compounds to which 259 
it was compared in this study. 260 
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Discussion 261 
The mycotoxin PXA is a toxic natural product whose mechanism of action has so far remained 262 
elusive. We provide evidence that PXA disrupts mitochondrial function and causes IMM 263 
fragmentation and cristae disruption independently of DRP1 and OPA1, leading to the release of pro-264 
apoptotic factors and ultimately to apoptosis. 265 
PXA, just like CCCP, dissipates ΔΨm within seconds. In the case of CCCP, respiration increases to 266 
compensate this, whereas PXA has the opposite effect and blocks respiration. Conversely, respiration 267 
is also blocked by ETC inhibitors, yet in contrast to PXA, these do not strongly affect ΔΨm. This 268 
suggests an entirely different mode of action for PXA. Additionally, unlike any of these compounds, 269 
PXA causes a strong mitochondrial release of Ca
2+
 and rapid fragmentation of the IMM but not the 270 
OMM. 271 
Release of mitochondrial Ca
2+
 and loss of ΔΨm can be results of persistent mPTP opening, yet we 272 
showed that PXA does not strongly affect the mPTP. Since mitochondrial ion gradients are 273 
interdependent through various antiporters that are generally linked to ΔΨm (ref. 2), one might assume 274 
that loss of ΔΨm disturbs these gradients sufficiently to induce a net Ca
2+
 efflux from the 275 
mitochondria. For CCCP, contradictory results have been reported – in some cases it caused Ca2+ 276 
release
21
, in some cases it did not
22
. We observed no effect of CCCP and most ETC inhibitors on 277 
[Ca
2+
]cyt, and in fact both ETC-deficient (ρ
0
) mitochondria
23
 and depolarised mitochondria
24
 can still 278 
facilitate a net uptake of Ca
2+
. It thus appears that the mitochondrial Ca
2+
 release induced by PXA is 279 
not necessarily a result of its effects on the ETC and ΔΨm, but rather that all of these effects might 280 
have a common cause. 281 
The delay between addition of PXA and the first observable increase in [Ca
2+
]cyt and decrease in 282 
[Ca
2+
]mitocontrasts with the immediate change in ΔΨm (Figure 3d). This discrepancy could possibly be 283 
explained by the hypothesis that mitochondria release Ca
2+
 mainly into the cristae, and that the cristae 284 
junctions may function as bottlenecks for mitochondrial Ca
2+
 transport
8,25
. Cristae junctions are 285 
regulated by OPA1, which is cleaved by OMA1 in response to mitochondrial stress, leading to cristae 286 
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disruption
26
. We not only showed that OPA1 is irreversibly cleaved by OMA1 upon PXA treatment, 287 
but that PXA also causes cristae disruption independently of OMA1. Thus, PXA-induced cristae 288 
disruption might cause the release of Ca
2+
 from the cristae and thus eventually into the cytosol. In 289 
addition, irreversible cristae disruption could well be a sufficient condition for the release of pro-290 
apoptotic factors and thus the induction of apoptosis
26,27,28
. 291 
OPA1 also affects the fragmentation of mitochondrial network structures, which can be induced by 292 
PXA as well as CCCP. In the case of CCCP, this is commonly explained by the excessive activation of 293 
DRP1 after increased OPA1 processing by OMA1, which in turn is a response to several kinds of 294 
cellular stress including impaired ATP production and loss of ΔΨm (ref. 
4,6,20,29,30,31,32
). Since PXA 295 
dissipates ΔΨm, inhibits ATP production and consequently induces OMA1-mediated OPA1 cleavage, 296 
one might assume that it induces fragmentation via the same mechanism, yet we observed PXA-297 
induced fragmentation events that were independent of DRP1, OMA1, and even OPA1. 298 
Mitochondrial fragmentation independent of DRP1 is an unusual phenomenon but has been reported 299 
in cells undergoing apoptosis after pro-apoptotic factors had already been released
33,34
. In the case of 300 
PXA, however, fragmentation occurs within minutes after treatment, whereas pro-apoptotic factors are 301 
released only after several hours. In addition, whereas both the OMM and IMM are divided together 302 
during DRP1-dependent fragmentation, PXA can cause exclusive fragmentation of the IMM while the 303 
OMM remains intact. This is surprising since no active mechanism for exclusive IMM fission is 304 
known in higher eukaryotes, and there are only few reports documenting this phenomenon
6,35,36
. 305 
The OMA1-processed short OPA1 forms play a role in IMM fission and cristae morphology
5,29,35
. 306 
However, since PXA-induced IMM fragmentation and cristae disruption are independent of both 307 
OMA1 and OPA1, this implies that OPA1 may well be an IMM fission regulator but not necessarily a 308 
fission executor. It has been recently proposed that OPA1 is dispensable for cristae junction biogenesis 309 
but may still be required for cristae junction remodelling
37
. Our results suggest that excessive OPA1 310 
processing may be sufficient but not necessary for inner membrane remodelling and cristae disruption 311 
and for the consequent release of pro-apoptotic factors. 312 
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The independence of PXA-induced IMM fragmentation from DRP1, OMA1, and OPA1, as well as its 313 
very fast onset, suggest that it might not depend on the fission/fusion machinery at all, but could work 314 
via a completely separate mechanism. Since no such mechanism is known in higher eukaryotes, any 315 
attempt at explaining this effect remains speculative. One explanation could be a change in IMM 316 
fluidity or matrix architecture, causing an immediate and strong retraction of the IMM. This could 317 
result from interference with the tethering of IMM and OMM at mitochondrial contact sites. If this is 318 
the case, a possible mechanistic target of PXA could be the mitochondrial phospholipid cardiolipin, 319 
which is present almost exclusively in the IMM and especially at mitochondrial contact sites
38,39
. 320 
Cardiolipin serves as a membrane anchor for many proteins that are implicated in mitochondrial 321 
contact site formation, mitochondrial ultrastructure, and the ETC, such as MIC27 (APOOL)
40,41
, F1FO 322 
ATP synthase
41,42
, CYCS
41
, and ETC complexes III and IV
41,43,44
. A disruptive interaction between 323 
PXA and either cardiolipin or cardiolipin-binding proteins might thus explain several of the effects 324 
induced by PXA. 325 
In summary, we identified PXA as a mitochondrial toxin with a mode of action distinct from known 326 
ETC inhibitors, OXPHOS uncouplers, and ionophores. Its effects, such as the rapid inhibition of both 327 
ETC and ΔΨm, the release of mitochondrial Ca
2+
, and the induction of DRP1- and OPA1-independent 328 
cristae disruption and fission of the inner but not the outer mitochondrial membrane, might render it a 329 
useful tool in studying these phenomena. Further studies may reveal the molecular target of PXA and 330 
the mechanisms through which it induces mitochondrial Ca
2+
 release and IMM fission. 331 
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Material and Methods 332 
Cell lines and cell culture 333 
Jurkat cells were obtained from DSMZ (#ACC-282). Ramos cells were kindly provided by Michael 334 
Engelke (Institute of Cellular and Molecular Immunology, University Hospital Göttingen, Göttingen, 335 
Germany). HeLa cells stably expressing mito-DsRed were kindly provided by Aviva M. Tolkovsky 336 
(Department of Clinical Neurosciences, University of Cambridge, England, UK) and have been 337 
described previously
45
. MEF cells deficient for OMA1 and/or YME1L1 as well as the corresponding 338 
wild-type cells were generated by Ruchika Anand and kindly provided by Thomas Langer (Institute 339 
for Genetics, University of Cologne, Germany) and have been described previously
29
. MEF cells 340 
deficient for DRP1 as well as the corresponding wild-type cells used for live imaging were kindly 341 
provided by Hiromi Sesaki (Department of Cell Biology, Johns Hopkins University, Baltimore, MD, 342 
USA) and have been described previously
33
. MEF cells deficient for DRP1 used for imaging of fixed 343 
cells were generated using the CRISPR/Cas9 system as described previously
46
. The DNA target 344 
sequence for the guide RNA was 5’-CAGTGGGAAGAGCTCAGTGC-3’. HCT116 cells were kindly 345 
provided by Frank Essmann (Interfaculty Institute of Biochemistry, Eberhard Karls University 346 
Tübingen, Germany). Transient expression of SMAC-mCherry and GFP-BAX was achieved by 347 
lipofection at 70–80% confluence using Lipofectamine 2000 (Life Technologies, Darmstadt, 348 
Germany). Cells were incubated with 0.15 µl Lipofectamine 2000, 50 ng pcDNA3-Smac(1-349 
60)mCherry (Addgene ID 40880; this plasmid was kindly provided by Stephen Tait (Beatson Institute, 350 
University of Glasgow, Scotland, UK) and has been described previously
47
), and 50 ng pGFP-Bax 351 
(kindly provided by Nathan R. Brady, Department of Molecular Microbiology and Immunology, 352 
Johns Hopkins University, Baltimore, MD, USA) per well in glass bottom 8-well chambers (Ibidi, 353 
Planegg, Germany) for 16 h. HeLa cells used for Ca
2+
 measurements were cultured in Dulbecco's 354 
modified Eagle's medium supplemented with 10% foetal calf serum (FCS) and 4 mM L-glutamine, 355 
100 U/ml penicillin and 100 μg/ml streptomycin at 37 °C and 5% CO2. They were authenticated using 356 
autosomal STR profiling performed by the University of Arizona Genetics Core and they fully 357 
matched the DNA fingerprint present in reference databases. Cell lines stably expressing either mito-358 
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DsRed (except HeLa; see above) or ratiometric mito-Pericam were generated by retroviral transfection 359 
using the Platinum-E (Plat-E) packaging cell line (kindly provided by Toshio Kitamura, Institute of 360 
Medical Science, University of Tokyo, Japan) and the retroviral vectors pMSCVpuro-mito-DsRed1 361 
(Addgene ID 87379) or pMSCVpuro-mito-Pericam (Addgene ID 87381). The medium used for the 362 
cultivation of Jurkat cells and Ramos cells was RPMI 1640 medium, and the medium used for 363 
cultivation of HCT116 cells was McCoy’s 5A medium. All other cells were cultivated in high-glucose 364 
DMEM. All media were supplemented with 10% FCS, 100 U/mL penicillin, and 100 µg/ml 365 
streptomycin. All cell lines were maintained at 37°C and 5% CO2 in a humidity-saturated atmosphere. 366 
Reagents 367 
Phomoxanthone A was isolated and purified as described previously
16
. We found that PXA becomes 368 
unstable if dissolved in DMSO and readily isomerises into the essentially non-toxic compound 369 
dicerandrol C (data not shown), in a process similar to the one previously described for the structurally 370 
related secalonic acids
48
. However, PXA is barely soluble in EtOH and not soluble in H2O. Therefore, 371 
PXA was prepared in small lyophilised aliquots and only dissolved in DMSO immediately before 372 
usage. 373 
The tyrosine phosphatase inhibitor pervanadate (VO4
3−
) was freshly prepared by mixing 30 mM 374 
sodium orthovanadate with 60 mM H2O2 in phosphate-buffered saline (PBS) and incubating at room 375 
temperature (RT) in the dark for 10 min; sodium orthovanadate was purchased from Sigma (Munich, 376 
Germany), #450243; ionomycin (IM) from Sigma, #I9657; thapsigargin (TG) from Sigma, #T9033; 377 
CGP-37157 from Cayman Chemical Company (Ann Arbor, MI, USA), #15611; carbonyl cyanide m-378 
chlorophenyl hydrazone (CCCP) from Sigma, #C2759; rotenone from Sigma, #45656; 379 
thenoyltrifluoroacetone (TTFA) from Sigma, #88300; antimycin A from Sigma, #A8674; sodium 380 
azide (NaN3) from Sigma, #S2002; oligomycin A from Toronto Research Chemicals (Toronto, 381 
Canada), #O532970; staurosporine (STS) from LC Laboratories (Woburn, MA, USA), #9300. All cell 382 
culture reagents were purchased from Life Technologies, and all other reagents where no manufacturer 383 
is explicitly mentioned were purchased from Carl Roth GmbH (Karlsruhe, Germany). 384 
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Replicates and statistical analysis 385 
Experiments were replicated at least three times, and representative data are shown. Error bars indicate 386 
standard deviation. All statistical analysis was performed using Prism v7.01 (GraphPad Software, La 387 
Jolla, CA, USA). 388 
In vitro kinase activity screening 389 
The effect of PXA on the activity of 141 protein kinases was assessed by the International Centre for 390 
Kinase Profiling (Dundee, Scotland, UK) using a radioactive filter binding assay with 
33
P ATP
49,50
. 391 
Live measurement of [Ca
2+
]cyt by Fluo-4-AM 392 
Cells were stained by incubation in growth medium containing 1 µM Fluo-4-AM (Life Technologies; 393 
#F14201), 0.005% w/v Pluronic F-127 (Sigma, #540025), 10 mM HEPES, and 5% v/v FCS at 30°C. 394 
After 25 min, an equal volume of full growth medium was added, the temperature was increased to 395 
37°C, and the cells were incubated for another 10 min. After that, the cells were washed and 396 
resuspended in Krebs-Ringer buffer (10 mM HEPES pH 7.0, 140 mM NaCl, 4 mM KCl, 1 mM 397 
MgCl2, 10 mM Glucose) supplemented with 1 mM CaCl2. The cells were kept at RT in the dark until 398 
measurement. Just before measurement, the cells were washed and resuspended in Krebs-Ringer 399 
buffer supplemented with 0.5 mM EGTA. Fluo-4-AM fluorescence was measured live using an 400 
LSRFortessa flow cytometer (BD, Franklin Lakes, NJ, USA) recording fluorescence in the FITC 401 
channel (Ex 488 nm, Em 530±30 nm). For each sample, after at least 30 s of baseline measurement, 402 
the stimulus was added and measurement was continued for at least 10 min. 403 
Live measurement of [Ca
2+
]mito and [Ca
2+
]ER by CEPIA 404 
Measurements of [Ca
2+
]mito and [Ca
2+
]ER in HeLa single cells were performed as described 405 
previously
51,52
, using the genetically-encoded Ca
2+
 indicators CEPIA3mt (Addgene ID 58219) and G-406 
CEPIA1er (Addgene ID 58215), respectively, which were developed by Dr. M. Iino (The University 407 
of Tokyo, Japan)
53
. The constructs were introduced into HeLa cells utilizing the X-tremeGENE HP 408 
DNA transfection reagent (Roche, Mannheim, Germany) according to the manufacturer's protocol. 409 
The [Ca
2+
] measurements were performed 48 h after transfection using a Zeiss Axio Observer Z1 410 
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Inverted Microscope equipped with a 20× air objective and a high-speed digital camera (Axiocam 411 
Hsm, Zeiss, Jena, Germany). Changes in fluorescence were monitored in the GFP channel 412 
(Ex 480 nm, Em 520 nm). Extracellular Ca
2+
 was chelated with 3 mM EGTA, and PXA (10 μM) or 413 
thapsigargin (1 μM) were added as indicated on the figures. All traces were normalized (F/F0) where 414 
F0 is the starting fluorescence of each trace. 415 
Live measurement of [Ca
2+
]mito by ratiometric mito-Pericam 416 
Ramos cells stably transfected with ratiometric mito-Pericam as described above were used for this 417 
measurement. Ratiometric mito-Pericam is a Ca
2+
 sensitive fluorescent protein and was described 418 
previously
54,55
. An increase in [Ca
2+
] causes a shift of the Pericam excitation maximum from ~410 nm 419 
to ~495 nm while the emission peak remains at ~515 nm. Pericam fluorescence was measured live 420 
using an LSRFortessa flow cytometer recording fluorescence in both the FITC channel (Ex 488 nm, 421 
Em 530±30 nm) and the AmCyan channel (Ex 405 nm, Em 525±50 nm). For each sample, after at 422 
least 30 s of baseline measurement, the stimulus was added and measurement was continued for at 423 
least 10 min. The ratio of fluorescence with excitation at 488 nm to 405 nm was calculated. 424 
Live measurement of mPTP opening by cobalt-calcein assay 425 
This method was adapted from previously published protocols
10,18,56
. The cells were stained by 426 
incubation in Krebs-Ringer buffer supplemented with 1 mM CaCl2, 1 mM CoCl2, and 1 µM calcein-427 
AM (Life Technologies, #65-0853-78) at 37°C for 30 min. After that, the cells were washed and 428 
maintained in Krebs-Ringer buffer supplemented with 1 mM CaCl2 and 1.6 µM cyclosporin H (CsH) 429 
to prevent passive efflux of calcein. For live measurement by confocal microscopy, imaging and 430 
quantification were performed using a Perkin Elmer Spinning Disc microscope with a 60× objective 431 
(oil-immersion and NA=1.49) at an excitation wavelength of 488 nm. The videos were obtained at 432 
1000 X 1000 pixel resolution with a Hamamatsu C9100 camera. Additional live measurement by flow 433 
cytometry was performed using an LSRFortessa flow cytometer recording fluorescence in the FITC 434 
channel (Ex 488 nm, Em 530±30 nm). For each sample, after at least 30 s of baseline measurement, 435 
the stimulus was added and measurement was continued for at least 10 min. 436 
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Isolation of live mitochondria 437 
Adherent cells were harvested by a cell scraper. All cells were pelletised by centrifugation at 600 rcf, 438 
resuspended in ice-cold mitochondria isolation buffer (210 mM mannitol, 70 mM sucrose, 1 mM 439 
K2EDTA, 20 mM HEPES), and passed through a 23G needle ten times. The resulting suspension was 440 
centrifuged at 600 rcf and the supernatant was transferred to a new tube and centrifuged at 6,500 rcf 441 
and 4°C for 15 min. The resulting mitochondrial pellet was resuspended in sodium-free mitochondrial 442 
respiration buffer MiR05 (0.5 mM EGTA, 3 mM MgCl2, 60 mM lactobionic acid, 20 mM taurine, 443 
10 mM KH2PO4, 20 mM HEPES, 110 mM D-sucrose, 0.1% w/v fatty acid-free BSA) supplemented 444 
with 10 mM succinate and 5 mM malate. 445 
Live measurement of mitochondrial Ca
2+
 retention capacity by calcium green 446 
Live mitochondria isolated as described above were stained by incubation in MiR05 buffer 447 
supplemented with 10 mM succinate, 5 mM malate, and 1 µM calcium green AM (Life Technologies, 448 
#C3012) for 20 min on a shaker at 37°C. Before measurement, the mitochondria were pelletised at 449 
6,500 rcf for 5 min, washed and resuspended in MiR05 supplemented with 10 mM succinate, 5 mM 450 
malate, and 5 µM of either CsH or CsA. In experiments where the mitochondria were loaded with Ca
2+
 451 
before measurement, this was achieved by incubation in MiR05 additionally supplemented with 452 
150 µM CaCl2 on a shaker at 37°C for 10 min after the first washing step and followed by a second 453 
washing step. 454 
Measurement of mitochondrial membrane potential by TMRE and TMRM 455 
For measurement in whole cells, the cells were stained by incubation in full growth medium 456 
containing 100 nM TMRE (AAT Bioquest, Sunnyvale, CA, USA; #22220) and 10 mM HEPES at 457 
37°C in the dark for 15 min. After that, the cells were washed and resuspended in full growth medium 458 
containing 10 mM HEPES and were incubated at 37°C in the dark for another 15 min. The cells were 459 
maintained at these conditions until measurement. For measurement in live mitochondria, these were 460 
isolated as described above, resuspended in sodium-free mitochondrial respiration buffer MiR05 461 
supplemented with 10 mM succinate, 5 mM malate, and 1 mM ADP, stained with 50 nM TMRM (Life 462 
Technologies, #T668) at 37°C for 15 min, and washed and resuspended in MiR05 additionally 463 
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supplemented with 1.6 µM cyclosporin H (CsH) to prevent passive TMRM leakage. For live 464 
measurement, TMRE or TMRM fluorescence was measured using an LSRFortessa flow cytometer 465 
recording fluorescence in the PE channel (Ex 488 nm, Em 575±26 nm). For each sample, after at least 466 
30 s of baseline measurement, the stimulus was added and measurement was continued for at least 467 
10 min. For the titration of the EC50 for mitochondrial depolarisation, TMRE fluorescence was 468 
measured using a Synergy Mx microplate reader (BioTek, Bad Friedrichshall, Germany) recording 469 
fluorescence at Ex 549±9 nm, Em 575±9 nm. TMRE fluorescence was measured right before and 470 
10 min after addition of PXA. EC50 values were calculated using Prism v7.01. 471 
Live O2 respirometry measurements 472 
This method was adapted from previously published protocols
19,57
. All measurements were performed 473 
using an OROBOROS Oxygraph-2k (Oroboros Instruments, Innsbruck, Austria). For measurement of 474 
total cellular respiration, intact cells (2×10
6
 cells/ml) were used and maintained in full growth medium 475 
supplemented with 20 mM HEPES during measurement. For direct measurement of mitochondrial 476 
respiration, digitonin-permeabilised cells (2×10
6
 cells/ml) were used and maintained in mitochondrial 477 
respiration buffer MiR05 during measurement. To induce respiration, 10 mM glutamate, 5 mM 478 
malate, 1 mM ADP, and 5 µg/ml digitonin were added. The following complex-specific ETC inducers 479 
were used: For complex II, 10 mM succinate (from Sigma, #S3674); for complex III, 1 mM 480 
tetramethylhydroquinone / duroquinol (from TCI Germany, Eschborn, Germany; #T0822); for 481 
complex IV, 50 µM tetramethyl-p-phenylenediamine (TMPD; from Sigma, #87890) supplemented 482 
with 200 µM ascorbate. 483 
Fluorimetric O2 consumption assay 484 
This measurement was performed using the MITO-ID® Extracellular O2 Sensor Kit (High Sensitivity) 485 
(Enzo Life Sciences, Lörrach, Germany; #51045) according to manufacturer’s instructions. 486 
Fluorescence was measured using a Synergy Mx microplate reader (Ex 340–400 nm, Em 630–680 nm; 487 
time-resolved fluorescence, delay time 30 µs, integration time 100 µs). 488 
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Measurement of cellular ATP levels 489 
This measurement was performed using the Mitochondrial ToxGlo™ Assay (Promega, Mannheim, 490 
Germany; #G8000) according to manufacturer’s instructions. Since most cancer cells prefer ATP 491 
synthesis by glycolysis over OXPHOS if glucose is present, this experiment was conducted in the 492 
presence of either glucose or galactose as the only available sugar, the latter of which reduces the net 493 
ATP yield of glycolysis to zero and forces the cells to resort to OXPHOS for ATP production
58,59
. 494 
Fluorimetric caspase-3 activity assay 495 
Caspase-3 activity was measured as described previously
60
. Briefly, cells were harvested by 496 
centrifugation at 600 rcf and lysed with 50 μl of ice-cold lysis buffer (20 mM HEPES, 84 mM KCl, 497 
10 mM, MgCl2, 200 μM EDTA, 200 μM EGTA, 0.5% NP-40, 1 µg/ml leupeptin, 1 μg/ml pepstatin, 498 
5 μg/ml aprotinin) on ice for 10 min. Cell lysates were transferred to a black flat-bottom microplate 499 
and mixed with 150 μl of ice-cold Reaction Buffer (50 mM HEPES, 100 mM NaCl, 10% sucrose, 500 
0.1% CHAPS, 2 mM CaCl2, 13.35 mM DTT, 70 μM Ac-DEVD-AMC). The kinetics of AMC release 501 
were monitored by measuring AMC fluorescence intensity (Ex 360 nm, Em 450 nm) at 37°C in 502 
intervals of 2 min over a time course of 150 min, using a Synergy Mx microplate reader. The slope of 503 
the linear range of the fluorescence curves (Δrfu/min) was considered as corresponding to caspase-3 504 
activity. 505 
Measurement of cell viability by MTT assay 506 
Cell viability was determined by the ability to convert the yellow MTT substrate (Roth, #4022) into a 507 
blue formazan product. MTT solution (5 mg/ml MTT in PBS) was added to cells to a final 508 
concentration of 1 mg/ml, and the cells were then incubated at 37°C for 60 min and pelletised at 509 
600 rcf. The supernatant was discarded and replaced with DMSO. After the formazan crystals were 510 
fully dissolved, absorption was measured (test wavelength 570 nm, reference wavelength 650 nm). 511 
Reference absorbance was subtracted from test absorbance. Cell-free medium samples were 512 
considered as having 0% viability and the average of the control samples was considered as having 513 
100% viability. IC50 values were calculated using Prism v7.01. 514 
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Immunoblotting 515 
Cells were harvested by centrifugation at 11,000 rcf in 4°C for 10 s, quick-frozen in liquid nitrogen, 516 
thawed on ice, incubated in Lysis Buffer (20 mM Tris-HCl, 150 mM NaCl, 1% v/v Triton X–100, 517 
0.5 mM EDTA, 1 mM Na3VO4, 10 mM NaF, 2.5 mM Na4P2O7, 0.5% sodium deoxycholate, protease 518 
inhibitor (Sigma, #P2714)) for 30 min and vortexed repeatedly. The cell lysates were then cleared 519 
from cell debris by centrifugation at 20,000 rcf for 15 min. SDS-PAGE and Western Blot were 520 
performed according to standard protocol. The antibodies used for protein detection were mouse anti-521 
phospho-tyrosine (Merck-Millipore, Darmstadt, Germany; clone 4G10, #05-1050); rabbit anti-OPA1 522 
(described previously
37
); mouse anti-ACTB (Sigma; clone AC-74, #A5316); and mouse anti-VCL 523 
(Sigma; clone hVIN-1, #V9131). 524 
Confocal microscopy 525 
Live imaging of HCT116 cells transiently expressing GFP-BAX and SMAC-mCherry was performed 526 
using a Zeiss LSM 710 ConfoCor3 microscope (Carl Zeiss, Jena, Germany) with a C‐Apochromat ×40 527 
N.A. 1.2 water immersion objective (Zeiss). Excitation light came from argon ion (488 nm) and HeNe 528 
(543 nm) lasers. The cells were maintained in full growth medium at 37°C and 5% CO2 during 529 
imaging. Images were recorded every 5 min and were processed with Fiji
61
. For each time frame, the 530 
standard deviation (SD) of the fluorescence intensity was measured for each channel. A low SD was 531 
considered as corresponding to homogenous distribution whereas a high SD was considered as 532 
corresponding to accumulation. 533 
Live imaging of HeLa cells stably expressing mito-DsRed was performed using a Cell Observer SD 534 
Dual Cam spinning disc confocal microscope (Zeiss) equipped with a C-Apochromat 63×, N.A. of 535 
1.45 oil immersion objective. Excitation light came from an argon ion (488 nm) and DPSS (561 nm) 536 
laser. The cells were maintained in full growth medium supplemented with 10 mM HEPES at 37°C 537 
during imaging. Images were recorded every 5 s. 538 
Live imaging of MEF cells stably expressing mito-DsRed was performed using a Perkin Elmer 539 
Spinning Disc microscope with a 60× objective (oil-immersion and NA=1.49) at an excitation 540 
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wavelength of 561 nm. The videos were obtained at 1000 X 1000 pixel resolution with a Hamamatsu 541 
C9100 camera. The cells were maintained in full growth medium supplemented with 10 mM HEPES 542 
at 37°C during imaging. 543 
For imaging of fixed HeLa and MEF cells, the cells were seeded on glass coverslips and grown to 60–544 
90% confluence prior to experiments. Cells were treated with either 10 M PXA, 10 M CCCP, or 545 
0.1% v/v DMSO for 30 min, and were fixed by incubation with pre-warmed 4% paraformaldehyde in 546 
PBS at 37C for 10 min. Coverslips were then washed once with PBS, followed by incubation with 547 
PBS supplemented with 0.5% Triton X-100 for 10 min at RT. The coverslips were washed 3 times for 548 
3–5 minutes with PBS supplemented with 0.2% Tween-20 (PBS-T). The coverslips were then 549 
incubated at RT for 30 min with Blocking Buffer (PBS-T supplemented with 0.2% fish gelatin and 5% 550 
goat serum) in a humidified box, followed by 1 h incubation with primary antibodies (anti-HSP60 551 
clone N-20, #sc-1052 and anti-TOMM20 clone FL-145, #sc-11415 both from Santa Cruz, Dallas, TX, 552 
USA) diluted in Blocking Buffer. The coverslips were then washed three times with PBS-T, and 553 
incubated with Blocking Buffer for 30 min before adding secondary antibodies (Alexa Fluor 488-554 
labelled donkey anti-goat and Alexa Fluor 594-labelled donkey anti-rabbit). Immunofluorescence 555 
images were acquired with a Marianas spinning disc confocal microscope (Intelligent Imaging 556 
Innovations, Denver, CO, USA). 557 
Transmission electron microscopy 558 
Transmission electron microscopy (TEM) samples were fixed for a minimum of 4 h in 2.5% v/v 559 
glutaraldehyde (GA) and 4% w/v paraformaldehyde (PFA) in 0.1 M cacodylate buffer (pH 7.4) at 4°C. 560 
Then, samples were incubated in 1% osmium tetroxide in 0.1 M cacodylate buffer for 2 h. 561 
Dehydration was achieved using acetone (50%, 70%, 90% and 100%) and block contrast was applied 562 
(1% phosphotungstic acid / 0.5% uranylacetate in 70% acetone). A SPURR embedding kit (Serva, 563 
Heidelberg, Germany) was used to embed samples, which were polymerized overnight at 70°C, before 564 
cutting into 80 nm sections using an Ultracut EM UC7 (Leica, Wetzlar, Germany). Images were 565 
captured using an H600 TEM (Hitachi, Tokyo, Japan) at 75kV. 566 
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Figure Legends 743 
Figure 1 PXA causes an increase of [Ca
2+
]cyt and a release of [Ca
2+
]mito but not [Ca
2+
]ER. (a) Live 744 
measurement of the effect of PXA (10 µM) on [Ca
2+
]cyt in Ramos cells, where DMSO (0.1% v/v) was 745 
used as vehicle control and ionomycin (IM; 2 µM) was used as positive control, and (b) live 746 
measurement of [Ca
2+
]cyt after PXA followed by Thapsigargin (TG; 10 µM). Measurements were 747 
performed by flow cytometry using the Ca
2+
-sensitive fluorescent probe Fluo-4-AM (Ex 488 nm, 748 
Em 530±30 nm) in the absence of extracellular Ca
2+
 by maintaining the cells in Krebs-Ringer buffer 749 
containing 0.5 mM EGTA during measurement. (c & d) Comparison of the effect of PXA (10 µM) 750 
and thapsigargin (TG; 1 µM) on either [Ca
2+
]ER or [Ca
2+
]mito as measured by the Ca
2+
 sensitive 751 
fluorescent protein CEPIA targeted to the respective organelle in HeLa cells. All traces were 752 
normalized (F/F0) where F0 is the starting fluorescence of each trace. (e) Comparison of the effect of 753 
PXA (10 µM), ionomycin (IM; 2 µM), and thapsigargin (TG; 1 µM) on [Ca
2+
]mito in Ramos cells 754 
stably transfected with the Ca
2+
 sensitive fluorescent protein ratiometric mito-Pericam. DMSO (0.1% 755 
v/v) was used as vehicle control. F/F0 is the ratio of fluorescence with excitation at 488 nm (high 756 
[Ca
2+
]) to 405 nm (low Ca
2+
]). (f & g) Live imaging and quantification of the effect of PXA (10 µM) 757 
on mPTP opening in HeLa cells as measured by mitochondrial calcein fluorescence using the 758 
calcein/cobalt quenching method. DMSO (0.1% v/v) was used as vehicle control and ionomycin (IM; 759 
2 µM) was used as positive control. Mitochondrial calcein fluorescence was quantified. (h) Additional 760 
live measurement of the effect of PXA on mPTP opening in Ramos cells by the calcein/cobalt 761 
quenching method using flow cytometry. 762 
Figure 2 Live measurement of the effect of PXA on mitochondrial Ca
2+
 retention capacity. Isolated 763 
mitochondria were stained with calcium green AM and maintained in the presence of either (a & c) 764 
CsH or (b & d) CsA, and fluorescence was measured either (a & b) directly after staining or (c & d) 765 
after first loading the mitochondria with 150 µM Ca
2+
. 766 
Figure 3 PXA dissipates the mitochondrial membrane potential (ΔΨm) but does not increase cellular 767 
respiration. (a) Live measurement of the effect of PXA (10 µM) on ΔΨm in Ramos cells. 768 
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Measurements were performed by flow cytometry using the ΔΨm-sensitive fluorescent probe TMRE 769 
(Ex 488 nm, Em 575±26 nm). A decrease in TMRE fluorescence corresponds to a decrease in ΔΨm. 770 
The protonophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP; 10 µM) was used as positive 771 
control for mitochondrial depolarisation. (b) Live measurement of the effect of PXA (10 µM) ΔΨm in 772 
isolated mitochondria. Measurements were performed by flow cytometry using the ΔΨm-sensitive 773 
fluorescent probe TMRM (Ex 488 nm, Em 575±26 nm). The mitochondria were maintained in the 774 
presence of 1.6 µM CsH to prevent passive TMRM leakage. (c) Titration of PXA to determine the 775 
effect on cellular respiration in Ramos cells as measured by oxygen consumption. CCCP was used as 776 
positive control for increase of respiration. Measurement of extracellular [O2] was performed using an 777 
oxygraph. (d) Comparison of the kinetics of the effects of PXA on [Ca
2+
]cyt (as measured by Fluo-4-778 
AM fluorescence), [Ca
2+
]mito (as measured by mito-Pericam fluorescence), O2 consumption (as 779 
measured by changes in extracellular [O2]), and ΔΨm (as measured by TMRE fluorescence). Graphs 780 
were partially adapted from other figures. 781 
Figure 4 Effect of PXA on electron transport chain and OXPHOS. (a) Live measurement of the effect 782 
of PXA on uncoupled cellular respiration in intact Ramos cells. Cells were first treated with 1 µM 783 
CCCP to uncouple respiration and then with either 10 µM PXA or 0.1% v/v DMSO (vehicle control) 784 
to test for inhibition. Measurement of extracellular [O2] was performed using an oxygraph. (b) 785 
Comparative measurements of the effect of PXA and other compounds on basal and uncoupled 786 
respiration in Ramos cells. Respiration was uncoupled by CCCP (1 µM). PXA (10 µM) was compared 787 
to the complex-specific ETC inhibitors rotenone (Rot; complex I; 10 µM), thenoyltrifluoroacetone 788 
(TTFA; complex II; 10 µM), antimycin A (AmA; complex III; 10 µM), azide (NaN3; complex IV; 789 
1 mM), and oligomycin A (OmA; complex V; 10 µM). Measurement was performed in a microplate 790 
reader using the fluorescence-based MITO-ID® Extracellular O2 Sensor Kit (High Sensitivity) (Enzo). 791 
(c) Comparative measurements of the effect of PXA and other compounds on ATP levels in Ramos 792 
cells after 120 min of treatment. PXA (10 µM) was compared to complex-specific ETC inhibitors (see 793 
above) as well as CCCP (1 µM). Measurement was performed in a microplate reader using the 794 
luminescence-based Mitochondrial ToxGlo™ Assay (Promega). Cells were incubated in full growth 795 
medium containing either glucose or galactose as the only available sugar. Galactose alone forces the 796 
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cells to resort exclusively to OXPHOS for ATP synthesis. (d) Live measurement of mitochondrial 797 
respiration in Ramos cells permeabilized by digitonin (Digi; 5 µg/ml). The effect of PXA (first 1 µM, 798 
then increased to 10 µM as indicated) was compared to that of the known complex I inhibitor rotenone 799 
(Rot; 1 µM). To specifically induce complex II and III of the electron transport chain, succinate (Succ; 800 
10 mM) and duroquinol (Duro; 1 mM) were used, respectively. Measurement of extracellular [O2] was 801 
performed using an oxygraph. 802 
Figure 5 Comparative measurements of the effect of PXA and other compounds on apoptosis 803 
induction and cytotoxicity in Jurkat and Ramos cells. PXA (10 µM) was compared to the 804 
protonophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP; 10 µM), the Ca
2+
 ionophore 805 
ionomycin (IM; 10 µM), the apoptosis inducer staurosporine (STS; 10 µM), and the complex-specific 806 
ETC inhibitors rotenone (Rot; complex I; 10 µM), antimycin A (AmA; complex III; 10 µM), and 807 
oligomycin A (OmA; complex V; 10 µM). Data shown are the means of three independent 808 
experiments; error bars = SD. (a & b) Measurement of apoptosis induction based on cleavage of the 809 
pro-fluorescent CASP3 substrate Ac-DEVD-AMC, which results in release of AMC (Ex 360 nm, 810 
Em 450 nm), as an indicator of apoptosis. (c & d) Measurement of cytotoxicity after 24 h of treatment 811 
in the presence of either glucose or galactose as the only available sugar. Galactose alone forces the 812 
cells to resort exclusively to OXPHOS for ATP synthesis. Measurement was performed in a 813 
microplate reader using the MTT viability assay. 814 
Figure 6 PXA causes irreversible OMA1-dependent OPA1 processing and primes cells for death (a) 815 
Effect of PXA (10 µM) and of the protonophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP; 816 
10 µM) on OPA1 processing in cells deficient for the OPA1 protease OMA1 and / or YME1L1. 817 
Proteins were detected by immunoblot. Beta-actin (ACTB) was used as loading control. (b) 818 
Examination of the recovery of long OPA1 forms in Ramos or Jurkat cells after 5 min of treatment 819 
with either PXA (10 µM) or CCCP (10 µM) followed by removal of the substance and a recovery 820 
period of up to 9 h. Proteins were detected by immunoblot. Vinculin (VCL) was used as loading 821 
control. (c) Comparison of the effect of PXA on cell viability if the stimulus was removed after 822 
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treatment. Measurement was performed in a microplate reader using the MTT viability assay. Data 823 
shown are the means of three independent experiments; error bars = SD. 824 
Figure 7 Effects of PXA on mitochondrial integrity and morphology. All scale bars are equivalent to 825 
10 µm. (a) Confocal live imaging of a HCT116 cell expressing GFP-BAX (green) and SMAC-826 
mCherry (magenta) after treatment with 10 µM PXA. (b) Confocal live imaging of a HeLa cell stably 827 
expressing the fluorescent dye mito-DsRed, which localises to the mitochondrial matrix, after 828 
treatment with 10 µM PXA. (c) Confocal live imaging of MEF cells (WT, OMA1-KO, OMA1-829 
YME1L1-DKO, and DRP1-KO) before and after treatment with 10 mM PXA. The cells are stably 830 
expressing the fluorescent dye mito-DsRed, which localises to the mitochondrial matrix. 831 
Figure 8 Effect of PXA on mitochondrial matrix morphology. (a) Confocal images of MEF cells (WT 832 
& DRP1-KO) at 30 min after treatment with either 0.1% v/v DMSO (vehicle control), 10 µM CCCP 833 
(positive control for fragmentation), or 10 µM PXA. HSP60 (green) was stained as a marker for the 834 
mitochondrial matrix, and TOMM20 (red) was stained as a marker for the outer mitochondrial 835 
membrane (OMM). Scale bars are equivalent to 10 µm. (b) Quantification of mitochondrial 836 
morphology by classification of 200 individual cells in each of three independent experiments; error 837 
bars = SD. (c) Transmission electron microscopy images of MEF cells (WT or OMA1-KO) after 838 
treatment with either 10 µM PXA or with 0.1% v/v DMSO (vehicle control) for 30 min. Scale bars are 839 
equivalent to 0.5 µm. 840 
Figure S1 Structure of phomoxanthone A (PXA), adapted from Rönsberg et al. 2013 (PMID 841 
24295452). 842 
Figure S2 Comparison of PXA to the tyrosine phosphatase inhibitor pervanadate (VO4
3−
). (a) 843 
Induction of Ca
2+
 release from intracellular stores in Ramos cells after treatment with either PXA 844 
(10 µM) or VO4
3−
 (30 µM). PXA Ca
2+
 trace adapted from Figure 1. (b) Effect of PXA (10 µM) and 845 
VO4
3−
 (30 µM) on tyrosine phosphorylation in Ramos cells as detected by immunoblotting. Untreated 846 
cells (UNTR) were used as control. 847 
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Figure S3 Titration of PXA to determine the EC50 for mitochondrial depolarisation (indicated by the 848 
dotted line), using the ΔΨm-sensitive fluorescent probe TMRE. Measurement was performed by a 849 
microplate reader after 10 min of treatment. Data shown are the means of three independent 850 
experiments; error bars = SD. 851 
Figure S4 Comparison of the effects of PXA and other compounds on [Ca
2+
]cyt, ΔΨm, and mPTP 852 
opening in Ramos cells. PXA was compared to the protonophore carbonyl cyanide m-chlorophenyl 853 
hydrazone (CCCP; 10 µM); to the Ca
2+
 ionophore ionomycin (10 µM); to the ETC inhibitors rotenone 854 
(10 µM; complex I), antimycin A (10 µM; complex III), azide (NaN3; 1 mM; complex IV), and 855 
oligomycin A (10 µM; complex V); and to the apoptosis inducer staurosporine (10 µM). (a) Effects on 856 
[Ca
2+
]cyt as measured by flow cytometry using the fluorescent Ca
2+
-sensitive dye Fluo-4-AM. All 857 
measurements were performed in the absence of extracellular Ca
2+
 by maintaining the cells in Krebs-858 
Ringer buffer containing 0.5 mM EGTA during measurement. (b) Effects on ΔΨm as measured by 859 
flow cytometry using the fluorescent ΔΨm-sensitive dye TMRE. 860 
Figure S5 Quantification of the effects of PXA on mitochondrial BAX accumulation and SMAC 861 
release in HCT116 cells. The normalised standard deviation (SD) of the fluorescence intensity of 862 
GFP-BAX and SMAC-mCherry upon treatment with PXA (10 µM) in individual cells (N=4) was used 863 
as a measure of distribution inside the cells. A low SD corresponds to homogenous distribution while 864 
a high SD corresponds to accumulation. Thinner lines represent measurements of individual cells, 865 
while thicker lines represent the average of all recorded cells. 866 
Figure S6 Confocal images of HeLa cells (WT, DRP1-KO, and DRP1-OPA1-DKO) at 30 min after 867 
treatment with either (a) 0.1% v/v DMSO (vehicle control) or (b) 10 µM PXA. HSP60 (green) was 868 
stained as a marker for the mitochondrial matrix, and TOMM20 (red) was stained as a marker for the 869 
outer mitochondrial membrane (OMM). 870 
Table S1 Effect of PXA on the activity of various protein kinases in vitro. 871 
Movie S1 Confocal live imaging of a HeLa cell stained with 1 µM calcein AM in the presence of 872 
1 mM CaCl2 and 1 mM CoCl2 and washed afterwards. DMSO (0.1% v/v) was added at t = 0. 873 
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Movie S2 Confocal live imaging of a HeLa cell stained with 1 µM calcein AM in the presence of 874 
1 mM CaCl2 and 1 mM CoCl2 and washed afterwards. PXA (10 µM) was added at t = 0. 875 
Movie S3 Confocal live imaging of a HeLa cell stained with 1 µM calcein AM in the presence of 876 
1 mM CaCl2 and 1 mM CoCl2 and washed afterwards. IM (2 µM) was added at t = 0. 877 
Movie S4 Confocal live imaging of a HCT116 cell expressing GFP-BAX (green) and SMAC-878 
mCherry (magenta). Scale bar equivalent to 10 µm. PXA was added at about t = 0. 879 
Movie S5 Confocal live imaging of a MEF cell (WT) stably expressing the fluorescent dye mito-880 
DsRed, which localises to the mitochondrial matrix. DMSO (0.1% v/v) was added at about t = 0. 881 
Movie S6 Confocal live imaging of a MEF cell (WT) stably expressing the fluorescent dye mito-882 
DsRed, which localises to the mitochondrial matrix. PXA (10 µM) was added at about t = 0. 883 
Movie S7 Confocal live imaging of a MEF cell (OMA1-YME1L1-DKO) stably expressing the 884 
fluorescent dye mito-DsRed, which localises to the mitochondrial matrix. PXA (10 µM) was added at 885 
about t = 20 s. 886 
Movie S8 Confocal live imaging of a MEF cell (DRP1-KO) stably expressing the fluorescent dye 887 
mito-DsRed, which localises to the mitochondrial matrix. PXA (10 µM) was added at about t = 9 min. 888 
 889 
